- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩336,500.00
7D
5.3%
1Y
-40.7%
Samsung BiologicsLtd
Market Cap: ₩64.6t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,396,000.00
7D
0.07%
1Y
-13.6%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,150.00
7D
-2.9%
1Y
-12.4%
JW Shinyak
Market Cap: ₩110.1b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,970.00
7D
29.5%
1Y
20.6%
JW Holdings
Market Cap: ₩270.2b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,905.00
7D
0%
1Y
5.7%
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,400.00
7D
-3.6%
1Y
-22.9%